Raymond James Financial Services Advisors, Inc. Inmune Bio, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 369,438 shares of INMB stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
369,438
Previous 227,534
62.37%
Holding current value
$1.8 Million
Previous $2.01 Million
0.75%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding INMB
# of Institutions
70Shares Held
5.9MCall Options Held
243KPut Options Held
46.4K-
Black Rock Inc. New York, NY813KShares$3.96 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR781KShares$3.8 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA721KShares$3.51 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$2.9 Million45.87% of portfolio
-
Geode Capital Management, LLC Boston, MA344KShares$1.68 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $87.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...